[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JO984B1 - K-clavulanate/tri hydrate formulations - Google Patents

K-clavulanate/tri hydrate formulations

Info

Publication number
JO984B1
JO984B1 JO1977984A JOP19770984A JO984B1 JO 984 B1 JO984 B1 JO 984B1 JO 1977984 A JO1977984 A JO 1977984A JO P19770984 A JOP19770984 A JO P19770984A JO 984 B1 JO984 B1 JO 984B1
Authority
JO
Jordan
Prior art keywords
clavulanate
tri hydrate
amoxicillin trihydrate
hydrate formulations
potassium
Prior art date
Application number
JO1977984A
Other languages
Arabic (ar)
Inventor
جون كراولي باتريك
Original Assignee
بيتشام غروب ليمتد
جون كراولي باتريك
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10423254&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JO984(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by بيتشام غروب ليمتد, جون كراولي باتريك filed Critical بيتشام غروب ليمتد
Application granted granted Critical
Publication of JO984B1 publication Critical patent/JO984B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A dry unit- dose pharmaceutical composition suitable for oral administration which composition comprises 20mg to 1500 mg of amoxicillin trihydrate, 20 mg to 500 mg of potassium clavulante and a pharmaceutically acceptable carrier with the proviso that the weight ratio of amoxicillin trihydrate to potassium clavulanate is from 6:1 to 1:1, has favoured storage properties ,such composition are presented in enclosed containers which they also contain a desiccant
JO1977984A 1977-10-11 1977-10-11 K-clavulanate/tri hydrate formulations JO984B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4219177 1977-10-11

Publications (1)

Publication Number Publication Date
JO984B1 true JO984B1 (en) 1979-12-01

Family

ID=10423254

Family Applications (1)

Application Number Title Priority Date Filing Date
JO1977984A JO984B1 (en) 1977-10-11 1977-10-11 K-clavulanate/tri hydrate formulations

Country Status (24)

Country Link
US (2) US4441609A (en)
JP (1) JPS5476831A (en)
AU (1) AU525089B2 (en)
BE (1) BE870988A (en)
CA (1) CA1105385A (en)
CH (1) CH642258A5 (en)
DE (1) DE2843318A1 (en)
FR (1) FR2405711A1 (en)
GB (1) GB2005538B (en)
HK (1) HK73785A (en)
IE (1) IE47450B1 (en)
IL (1) IL55660A (en)
IT (1) IT1109273B (en)
JO (1) JO984B1 (en)
KE (1) KE3525A (en)
MT (1) MTP836B (en)
MY (1) MY8500996A (en)
NL (1) NL190631B (en)
NZ (1) NZ188497A (en)
PL (1) PL210174A1 (en)
PT (1) PT68600A (en)
SE (2) SE435899B (en)
SG (1) SG34985G (en)
ZA (1) ZA785682B (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
IT1059403B (en) * 1975-02-07 1982-05-31 Glaxo Lab Ltd PROCEDURE FOR PRODUCING CLAVULANIC ACID AND ITS DERIVATIVES AS WELL AS COMPOSITIONS CONTAINING IT
EP0008905B1 (en) * 1978-09-06 1983-02-16 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
GR70283B (en) 1979-10-02 1982-09-03 Beecham Group Ltd
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
US4406887A (en) * 1981-10-13 1983-09-27 Bristol-Myers Company Method for treating resistant bacteria including anaerobes
DE3266580D1 (en) * 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
US5743398A (en) * 1984-05-22 1998-04-28 Southpac Trust International, Inc. Floral wrapper utilizing a breathable packaging material
FR2593152B1 (en) * 1986-01-22 1988-12-23 Adir WATERPROOF PACKAGING IN THE FORM OF ALVEOLAR PLATES ALLOWING FOR GAS EXCHANGES BETWEEN THE ALVEOLES.
EP0273209B1 (en) * 1986-12-30 1992-01-15 American Cyanamid Company Composition of matter containing polycarbophil
GB9007143D0 (en) * 1990-03-30 1990-05-30 Beecham Group Plc Veterinary composition
US5814337A (en) * 1992-10-07 1998-09-29 Beecham Group Plc Pharmaceutical formulation
GB9009446D0 (en) * 1990-04-26 1990-06-20 Beecham Group Plc Veterinary composition
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
GB9201639D0 (en) * 1992-01-25 1992-03-11 Smithkline Beecham Plc Pharmaceutical formulations
GB9408117D0 (en) 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9411626D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Package
US5947274A (en) * 1994-08-05 1999-09-07 Smithkline Beecham P.L.C. Desiccating container for moisture-sensitive material
GB9416599D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ2028A1 (en) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Medicines used to treat bacterial infections in pediatrics.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
EP1093812A3 (en) * 1995-09-07 2001-06-06 SmithKline Beecham Corporation Amoxycillin and clavulanate containing pharmaceutical formulation
AT403375B (en) * 1995-11-15 1998-01-26 Biochemie Gmbh METHOD FOR FILLING ALKALINE SALTS OF CLAVULANIC ACID
ITMI952354A1 (en) * 1995-11-16 1997-05-16 Smithkline Beecham Spa PHARMACEUTICAL COMPOSITION
AT407701B (en) * 1996-08-12 2001-05-25 Biochemie Gmbh Mixture which is suitable for direct tableting and contains as essential components amoxicillin trihydrate and the calcium salt of clavulanic acid, and process for preparing this mixture
AT407214B (en) * 1996-03-13 2001-01-25 Biochemie Gmbh Process for the preparation of excipient-free agglomerates of beta-lactam antibiotics
TWI225402B (en) 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
US6180708B1 (en) 1996-06-28 2001-01-30 W. R. Grace & Co.-Conn. Thermoplastic adsorbent compositions containing wax and insulating glass units containing such compositions
US6112888A (en) * 1996-06-28 2000-09-05 W. R. Grace & Co.-Conn. Non-reclosable packages containing desiccant matrix
GB9616536D0 (en) * 1996-08-06 1996-09-25 Quadrant Holdings Cambridge Co-amoxiclav dosage form
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
AU728526B2 (en) * 1997-02-14 2001-01-11 Smithkline Beecham Corporation Pharmaceutical formulations comprising amoxocyllin and clavulanate
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
WO2000025751A2 (en) * 1998-10-30 2000-05-11 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
CA2380820A1 (en) * 1999-08-16 2001-02-22 Revaax Pharmaceuticals, Llc Neurotherapeutic clavulanate composition and method
SI20411A (en) * 1999-12-22 2001-06-30 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Watersoluble powders for peroral solution and their use
US6905016B2 (en) * 2000-03-14 2005-06-14 Noven Pharmaceuticals, Inc. Packaging system for transdermal drug delivery systems
AT412213B (en) * 2000-05-30 2004-11-25 Sandoz Ag METHOD FOR DRYING AMOXICILLIN OR AMOXICILLIN-CONTAINING, ORAL, SOLID PHARMACEUTICAL COMPOSITIONS USING A GAS WITH A DEFINED GAS HUMIDITY
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US20060039967A1 (en) * 2002-08-12 2006-02-23 Motohiro Ohta Amino acid-containing chewable
US7341742B2 (en) * 2002-09-30 2008-03-11 L. Perrigo Company Simethicone containing tablet composition and method
MY147756A (en) * 2005-05-25 2013-01-15 Theravance Inc Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
DE102006007830A1 (en) * 2006-02-17 2007-08-30 Grünenthal GmbH Storage-stable oral dosage form of amoxicillin and clavulanic acid
CA2691451C (en) 2007-06-21 2015-03-24 Sara H. Fan Instrument and receptacles for performing processes
US20100255099A1 (en) * 2007-10-26 2010-10-07 Rexahn Pharmaceuticals, Inc. Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
JP2011500811A (en) * 2007-10-26 2011-01-06 レクサン ファーマシューティカルズ インコーポレイテッド Clavulanic acid pharmaceutical formulation
TR200909787A2 (en) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Pharmaceutical formulations containing a third generation cephalosporin and clavulanic acid.
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) * 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3128135A (en) * 1962-05-29 1964-04-07 Anaconda Wire & Cable Co Moisture-free package
US3567085A (en) * 1968-12-02 1971-03-02 James G Flores Neck-supported pill container
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions

Also Published As

Publication number Publication date
US4441609A (en) 1984-04-10
SE435899B (en) 1984-10-29
SE7810591L (en) 1979-04-12
IT1109273B (en) 1985-12-16
CH642258A5 (en) 1984-04-13
FR2405711A1 (en) 1979-05-11
MTP836B (en) 1979-05-11
IL55660A (en) 1981-09-13
PT68600A (en) 1978-10-01
JPS6341886B2 (en) 1988-08-19
AU4050678A (en) 1980-04-17
GB2005538B (en) 1982-05-26
PL210174A1 (en) 1980-08-11
NZ188497A (en) 1981-05-01
IT7851415A0 (en) 1978-10-09
IE782019L (en) 1979-04-11
AU525089B2 (en) 1982-10-21
BE870988A (en) 1979-04-03
MY8500996A (en) 1985-12-31
HK73785A (en) 1985-10-04
IE47450B1 (en) 1984-03-21
SE451668B (en) 1987-10-26
CA1105385A (en) 1981-07-21
IL55660A0 (en) 1978-12-17
US4301149A (en) 1981-11-17
ZA785682B (en) 1979-09-26
NL7810176A (en) 1979-04-17
NL190631B (en) 1994-01-03
DE2843318A1 (en) 1979-04-12
GB2005538A (en) 1979-04-25
SG34985G (en) 1985-11-15
JPS5476831A (en) 1979-06-19
FR2405711B1 (en) 1982-10-29
SE8107592L (en) 1981-12-17
KE3525A (en) 1985-05-31

Similar Documents

Publication Publication Date Title
JO984B1 (en) K-clavulanate/tri hydrate formulations
ES8307095A1 (en) Pharmaceutical Formulation.
CA2123321A1 (en) Combination chemotherapy
SG43037A1 (en) New esters of bi-and tricyclic aminoalcohols their preparation and their use in pharmaceutical compositions
AU2553992A (en) Bone-growth-stimulating composition
HUT49280A (en) Ointment for the peroral administration of medicine and process for producing the composition
IL91656A0 (en) Pharmaceutical composition containing a benzodiazepine derivative
MD1813C2 (en) Purified cyclodextrin derivatives of sulphoalkyl ethers or mixtures thereof, clathrate complex of cyclodextrin derivatives with medicamental content and pharmaceutical composition
CA2227887A1 (en) Pharmaceutical compositions of conjugated estrogens and methods for their use
NZ337418A (en) Paracetamol composition with improved rate of absorption
IL50930A (en) 1-alkyl-4-oxo-1,6,7,8-tetrahydro-4h-pyrido(1,2-a)pyrimidine-3-carboxamide derivatives,their preparation and pharmaceutical compositions containing them
ES8800040A1 (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
GB2258397A (en) Pharmaceutical compositions containing amethocaine
GR3007347T3 (en)
ES368325A1 (en) Cephalosporius having a thioltherified methyl group in the 3-position
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
EP0003200A3 (en) Use of tetrahydropyridinyl indole derivatives as medicines, and pharmaceutical compositions containing them
IL41034A (en) 6-aza-3h-1,4-benzodiazepines and 6-aza-1,2-dihydro-3h-1,4-benzodiazepines their preparation and pharmaceutical compositions containing them
GB1446237A (en) Pharmaceutical preparations containing pyrazolones
GB1465771A (en) Pharmaceutical composition and use thereofd
KR940000108A (en) Pharmacological soft capsules containing lysine clonicsinate and method for preparing the same
IL46755A (en) 2,3,8,12b-tetrahydro-1h-3a,8-methanodibenzo(3,4:6,7)-cyclohepta(1,2-c) pyrrole derivatives,their preparation and pharmaceutical compositions containing them
GB876320A (en) Pharmaceutical compositions containing d-3:5-diiodothyronine
CA1028248A (en) Pharmaceutical composition containing mg and k compounds